Martin-Ridaura, Carmen
Ochoa-Esteban, Darío
Berlinches-Zapero, Carmen
Ruiz-Fernández, Dolores
Sanz-Martín, Vanessa
Gavira-Izquierdo, Rosario
March, Sebastià
López-Toribio, María
Ceinos-Arcones, Mercedes
Rivas-Hernández, Dolores
Pino-Vega, Saray
Melero-Rubio, Juan Manuel
Bordel-Nieto, Francisco
Caballero-Jauregui, Milagros
Corella-Monzon, Isabel
Pino-Días, Raquel
Cutanda-Rodriguez, Carmen
Sánchez-Muñoz, Sergio
Fernández-Garrido, José Manuel
Morales-López, Carmen
Majarrez-Arias, María Jesús
Sancho, Santiago
Fernández, Nuria Calle
Martínez-Cortes, Mercedes
García-Crespo, Pilar
León-Dominguez, Carmen María
Pascual, Marina
Herrera, Raquel
,
Article History
Received: 4 May 2022
Accepted: 28 September 2022
First Online: 16 November 2022
Competing interests
: The authors declare that they have no competing interests. The ALAS intervention was designed and developed by Madrid Salud, a municipal public service. The APLICA cooperative was responsible for the analysis of the evaluation. The evaluation was funded by Novo Nordisk as part of the international project Cities Changing Diabetes. These three agents were coordinated but independent in their contributions. The funders did not influence the design of the intervention or the evaluation. Madrid Salud did not influence the results of the evaluation. The APLICA cooperative did not influence the design or development of the intervention.